The initiative's four research projects will use use genetic and other technologies to detect and treat cancer at its earliest stages.
Johns Hopkins' Evgeny Izumchenko is also developing a blood test for the non-invasive detection and followup of early tumors.
A Johns Hopkins team reported its finding in JAMA Cardiology, backed by SNP array data from 21,870 participants culled from several large cardiovascular studies.
A new set of papers reveals a range of gene expression influencers, identified using thousands of samples collected for the Genotype-Tissue Expression project.
In PNAS this week: links between the gut microbiome and multiple sclerosis, and more.
Hopkins' Joshua Sharfstein writes at JAMA Forum about how the Trump administration has been dealing with scientific evidence.
Johns Hopkins researchers added protein analysis to circulating tumor DNA testing to better detect early-stage pancreatic cancer.
Investigators retraced features contributing to Lyme disease spread by sequencing 146 Borrelia burgdorferi isolates collected in North America since the 1980s.
Using blood samples from 200 cancer patients, researchers showed that it is possible to find most early cancer cases with targeted error correction sequencing.
The company plans to develop tests for prostate cancer risk assessment, prostate cancer screening, and breast cancer screening.
A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.
A new analysis finds some cancers receive more nonprofit dollars than others.
An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.
In Science this week: comparative analysis of sex differences in mammal gene expression, and more.